599 Real-life tolerability of PARP inhibitors using specific PRO-CTCAE questionnaires: a single centre experience in ovarian cancer
2016 ◽
Vol 64
(2)
◽
pp. S246-S247
◽
2019 ◽
Vol 234
◽
pp. e67
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. e16500-e16500